JPWO2022208113A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022208113A5
JPWO2022208113A5 JP2023560997A JP2023560997A JPWO2022208113A5 JP WO2022208113 A5 JPWO2022208113 A5 JP WO2022208113A5 JP 2023560997 A JP2023560997 A JP 2023560997A JP 2023560997 A JP2023560997 A JP 2023560997A JP WO2022208113 A5 JPWO2022208113 A5 JP WO2022208113A5
Authority
JP
Japan
Prior art keywords
dimethyl
cyclopropyl
azabicyclo
carboxamide
hexane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023560997A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024511881A (ja
JP2024511881A5 (https=
Publication date
Priority claimed from GBGB2104742.8A external-priority patent/GB202104742D0/en
Priority claimed from GBGB2107026.3A external-priority patent/GB202107026D0/en
Application filed filed Critical
Priority claimed from PCT/GB2022/050836 external-priority patent/WO2022208113A1/en
Publication of JP2024511881A publication Critical patent/JP2024511881A/ja
Publication of JPWO2022208113A5 publication Critical patent/JPWO2022208113A5/ja
Publication of JP2024511881A5 publication Critical patent/JP2024511881A5/ja
Pending legal-status Critical Current

Links

JP2023560997A 2021-04-01 2022-04-01 ＳＡＲＳ－ＣＯＶ－２ Ｍｐｒｏ阻害剤化合物 Pending JP2024511881A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB2104742.8 2021-04-01
GBGB2104742.8A GB202104742D0 (en) 2021-04-01 2021-04-01 Sars-Cov-2 MPRO inhibitor compounds
GBGB2107026.3A GB202107026D0 (en) 2021-05-17 2021-05-17 SARS-COV-2 MPRO inhibitor compounds
GB2107026.3 2021-05-17
PCT/GB2022/050836 WO2022208113A1 (en) 2021-04-01 2022-04-01 Sars-cov-2 mpro inhibitor compounds

Publications (3)

Publication Number Publication Date
JP2024511881A JP2024511881A (ja) 2024-03-15
JPWO2022208113A5 true JPWO2022208113A5 (https=) 2025-04-09
JP2024511881A5 JP2024511881A5 (https=) 2025-04-09

Family

ID=81307814

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023560997A Pending JP2024511881A (ja) 2021-04-01 2022-04-01 ＳＡＲＳ－ＣＯＶ－２ Ｍｐｒｏ阻害剤化合物

Country Status (7)

Country Link
US (1) US20240217930A1 (https=)
EP (1) EP4313305A1 (https=)
JP (1) JP2024511881A (https=)
KR (1) KR20240004275A (https=)
AU (1) AU2022247287A1 (https=)
CA (1) CA3213008A1 (https=)
WO (1) WO2022208113A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024525589A (ja) 2021-07-09 2024-07-12 アリゴス セラピューティクス インコーポレイテッド 抗ウイルス化合物
WO2023043816A1 (en) 2021-09-17 2023-03-23 Aligos Therapeutics, Inc. Anti-viral compounds for treating coronavirus, picornavirus, and norovirus infections
GB202214644D0 (en) * 2022-10-05 2022-11-16 Heptares Therapeutics Ltd Sars-cov-2 mpro inhibitors and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7244721B2 (en) * 2000-07-21 2007-07-17 Schering Corporation Peptides as NS3-serine protease inhibitors of hepatitis C virus
CN1498224A (zh) * 2000-07-21 2004-05-19 ���鹫˾ 用作丙型肝炎病毒ns3-丝氨酸蛋白酶抑制剂的新型肽
CA3180177A1 (en) * 2020-05-08 2021-11-11 The Board Of Trustees Of The Leland Stanford Junior University Protease inhibitors for treatment or prevention of coronavirus disease

Similar Documents

Publication Publication Date Title
RU2494095C2 (ru) Модифицированные миметики лизина
US10173989B2 (en) 1,2,4-oxadiazole derivatives as immunomodulators
TW202327569A (zh) 包含ｔｅａｄ抑制劑的藥物組合及其用於癌症治療之用途
CN115884810A (zh) 作为il-17调节剂的咪唑并哒嗪
CN104395288B (zh) 用于治疗尤文肉瘤家族肿瘤的方法和组合物
SI9420017A (en) Hiv protease inhibitors in pharmaceutical combinations for the treatment of aids
JP2019525962A (ja) ケモカイン受容体調節剤及びそれの使用
RU2012138257A (ru) Замещенные пирролидин-2-карбоксамиды
IL287470B1 (en) Derivatives of 6-methyl-6,1-dihydro-7H-pyrrolo[3,2-c]pyridin-7-one or of an acceptable pharmaceutical salt thereof and pharmaceutical preparations containing them.
JP6217866B2 (ja) Ｋｃｎｑ２〜５チャネル活性化剤
JP2021513972A (ja) 社会的機能障害の治療方法
JP4746713B2 (ja) 環状アミン−１−カルボン酸エステル誘導体およびそれを含有する医薬組成物
JP2019516707A5 (https=)
JPWO2022208113A5 (https=)
JP2023062064A5 (https=)
IL293703A (en) Lysine-specific histone demethylase inhibitors for the treatment of myeloproliferative neoplasms
JP7158464B2 (ja) カリウムチャネル阻害剤としての置換ベンゾイミダゾール
CN118119613A (zh) 作为il-17调节剂的苯并咪唑
JP2009521417A5 (https=)
CN102112451B (zh) 用作趋化因子受体调节剂的二氮杂环庚烷和哌嗪衍生物
CN107074771A (zh) 可溶性环氧化物水解酶抑制剂及其用途
JPWO2020249802A5 (https=)
HRP20130992T1 (hr) Derivati arilpirazinona kao stimulatori luäśenja inzulina, postupci za njihovo dobivanje i njihova uporaba za lijeäśenje dijabetesa
JPWO2023104882A5 (https=)
CN1738613A (zh) 包含(+)－3－(3,4－二甲氧基－苯基)－3－(1－氧代－1,3－二氢－异吲哚－2－基)－丙酰胺的组合物及其使用方法